Upregulated miR-106a plays an oncogenic role in pancreatic cancer. (Q53071807)

11 May 2018

title

Upregulated miR-106a plays an oncogenic role in pancreatic cancer. (English)

1 reference

11 May 2018

author name string

Pei Li

1

1 reference

11 May 2018

Qinhong Xu

2

1 reference

11 May 2018

Dong Zhang

3

1 reference

11 May 2018

Xuqi Li

4

1 reference

11 May 2018

Liang Han

5

1 reference

11 May 2018

Jianjun Lei

6

1 reference

11 May 2018

Wanxing Duan

7

1 reference

11 May 2018

Qingyong Ma

8

1 reference

11 May 2018

Zheng Wu

9

1 reference

11 May 2018

Zheng Wang

10

1 reference

11 May 2018

language of work or name

English

0 references

publication date

18 January 2014

1 reference

11 May 2018

published in

FEBS Letters

1 reference

11 May 2018

volume

588

1 reference

11 May 2018

issue

5

1 reference

11 May 2018

page(s)

705-712

1 reference

11 May 2018

MicroRNA signatures in human cancers

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

miR-106a overexpression and pRB downregulation in sporadic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Circulating microRNAs in plasma of patients with gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Fecal MicroRNAs as novel biomarkers for colon cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Real-time quantification of microRNAs by stem-loop RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

To cycle or not to cycle: a critical decision in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Cellular mechanisms of tumour suppression by the retinoblastoma gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Emerging roles of RB family: new defense mechanisms against tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Colorectal cancer migration and invasion initiated by microRNA-106a

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Invasive markers identified by gene expression profiling in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

BMP2 induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

A MicroRNA targeting dicer for metastasis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2014.01.007

10.1016/J.FEBSLET.2014.01.007

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

24444603

1 reference

11 May 2018